Home » Topics » BioWorld Science

BioWorld Science
RSS

Multitarget kinase inhibitors disclosed by Bukwang Pharmaceutical

Aug. 23, 2018

Korea Research Institute of Chemical Technology, Dong-Wha Pharmaceuticals describe BRD4 inhibitors

Aug. 23, 2018

Kyoto University, Astellas present CDK8/CDK19 dual inhibitors

Aug. 23, 2018

Ancureall Biomedical Technology divulges histone-lysine N-methyltransferase EZH2 inhibitors

Aug. 23, 2018

Sichuan University describes inhibitors of mutant FLT-3 kinase

Aug. 23, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

NEU-4438: an advanced lapatinib-derived lead compound against trypanosomiasis

Aug. 23, 2018

Genentech describes discovery of a highly potent SERD for treatment of cancer

Aug. 23, 2018

VBX-100 demonstrates positive safety data in vitro

Aug. 23, 2018

DSMB reaffirms its recommendation to continue the phase II XanADu study

Aug. 23, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...